Valacyclovir Treatment for HSV-1 Infections

Direct Recommendation

• The CDC recommends valacyclovir 500 mg orally twice daily for 5 days as the first-line episodic regimen for HSV-1 infections 1, 2

Treatment Approach by Clinical Scenario

Episodic Treatment of Recurrent HSV-1 Outbreaks

• The CDC recommends starting treatment during prodrome or within 1 day of lesion onset for maximum effectiveness 1
• Valacyclovir 500 mg orally twice daily for 5 days is the recommended episodic treatment regimen for immunocompetent patients 1, 2

Suppressive Therapy for Frequent Recurrences

• The American College of Obstetricians and Gynecologists and CDC consider daily suppressive therapy if patients experience ≥6 recurrences per year 1
• Valacyclovir 500 mg orally once daily is effective and FDA-approved for once-daily suppressive dosing 1, 3
• Valacyclovir 1 g orally once daily is an alternative for patients with very frequent recurrences (≥10 episodes/year) 1, 3
• Suppressive therapy reduces recurrence frequency by ≥75% and decreases asymptomatic viral shedding 1

Severe or Complicated HSV-1 Disease

• For severe disease requiring hospitalization, switch to intravenous acyclovir, with a dose of 5-10 mg/kg IV every 8 hours for 5-7 days or until clinical resolution 2, 3

Immunocompromised Patients

• Immunocompromised patients require higher doses and longer treatment durations, with oral therapy consisting of acyclovir 400 mg orally 3-5 times daily until clinical resolution 2, 3
• Severe cases in immunocompromised patients should be treated with acyclovir 5 mg/kg IV every 8 hours until clinical resolution 2

Important Clinical Considerations

Comparative Efficacy

• Valacyclovir demonstrates equivalent clinical efficacy to acyclovir in controlled trials, with improved convenience due to twice-daily or once-daily dosing 3

Safety Profile

• Allergic reactions to valacyclovir are infrequent 3

Common Pitfalls to Avoid

• Topical acyclovir is substantially less effective than oral therapy and should not be used 1
• Valacyclovir 500 mg once daily appears less effective in patients with very frequent recurrences (≥10 episodes/year); use 1 g once daily instead 3
• Suppressive therapy reduces but does not eliminate asymptomatic viral shedding, so transmission risk remains 3

Patient Counseling Points

• Genital herpes is incurable; antiviral medications control symptoms but do not eradicate the virus 1
• Abstain from sexual activity when lesions or prodromal symptoms are present 1
• Asymptomatic viral shedding can occur, potentially leading to transmission even without visible lesions 1
• Use condoms during all sexual exposures with new or uninfected partners 1